Literature DB >> 18775355

Obesity and dyslipidemia.

Remco Franssen1, Houshang Monajemi, Erik S G Stroes, John J P Kastelein.   

Abstract

The alarming and still increasing prevalence of obesity and associated cardiovascular risk raises much concern. The increase in cardiovascular risk depends to a significant extent on the changes in lipid profiles as observed in obesity. These changes are decreased high-density lipoprotein cholesterol and increased triglyceride levels. Much effort has already been expended into the elucidation of the mechanisms behind these obesity-associated lipid changes. Insulin resistance certainly plays a central role and, in addition, both hormonal and neurologic pathways have recently been found to play an important role. This article focuses on the mechanisms involved in the development of the proatherogenic lipid changes associated with obesity.

Entities:  

Mesh:

Year:  2008        PMID: 18775355     DOI: 10.1016/j.ecl.2008.06.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  11 in total

Review 1.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

2.  Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania.

Authors:  Helen Semu; Rachel M Zack; Enju Liu; Ellen Hertzmark; Donna Spiegelman; Kevin Sztam; Claudia Hawkins; Guerino Chalamila; Aisa Muya; Hellen Siril; Ramadhani Mwiru; Deo Mtasiwa; Wafaie Fawzi
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-08-21

3.  Trends in serum lipids and hypertension prevalence among non-pregnant reproductive-age women: United States National Health and Nutrition Examination Survey 1999-2008.

Authors:  Tabassum H Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  Matern Child Health J       Date:  2013-10

4.  Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects.

Authors:  Hye Duck Choi; Yeo Kyu Youn; Wan Gyoon Shin
Journal:  Plant Foods Hum Nutr       Date:  2011-11       Impact factor: 3.921

5.  Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats.

Authors:  Chia Hui Apphia Eu; Wai Yen Alfred Lim; So Ha Ton; Khalid bin Abdul Kadir
Journal:  Lipids Health Dis       Date:  2010-07-29       Impact factor: 3.876

6.  Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled cross-over trial.

Authors:  Mohsen Moohebati; Shima Yazdandoust; Amirhossein Sahebkar; Mohsen Mazidi; Zahra Sharghi-Shahri; Gordon Ferns; Majid Ghayour-Mobarhan
Journal:  ARYA Atheroscler       Date:  2014-09

Review 7.  Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review.

Authors:  Benjamin J Tilley; Jill L Cook; Sean I Docking; James E Gaida
Journal:  Br J Sports Med       Date:  2015-10-15       Impact factor: 13.800

8.  Acute aflatoxin B1 - Induced hepatotoxicity alters gene expression and disrupts lipid and lipoprotein metabolism in rats.

Authors:  Oluwakemi Anuoluwapo Rotimi; Solomon Oladapo Rotimi; Chibueze Uchechukwu Duru; Ogheneworo Joel Ebebeinwe; Anthonia Obhio Abiodun; Boluwaji Oluwamayowa Oyeniyi; Francis Adedayo Faduyile
Journal:  Toxicol Rep       Date:  2017-07-24

9.  Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population.

Authors:  Janina Petkeviciene; Alina Smalinskiene; Dalia Ieva Luksiene; Kristina Jureniene; Vitalija Ramazauskiene; Jurate Klumbiene; Vaiva Lesauskaite
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

Review 10.  Leptin signaling molecular actions and drug target in hepatocellular carcinoma.

Authors:  Nan Jiang; Rongtong Sun; Qing Sun
Journal:  Drug Des Devel Ther       Date:  2014-11-14       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.